Zivastine: Next-Generation 24-Hour Relief from Allergic Rhinitis & Chronic Urticaria

1. What is Zivastine?

Zivastine is a second-generation, long-acting histamine -receptor antagonist formulated with Ebastine. Developed to provide comprehensive control over allergic reactions, Zivastine targets both respiratory symptoms and dermatological allergy manifestations.

Manufactured by Zein Pharma, Zivastine is delivered in modern Orodispersible Tablets (ODT) across flexible 10 mgand 20 mg dosage strengths. The fast-dissolving formulation ensures rapid absorption without requiring water, offering convenient on-the-go administration.

2. Key Clinical Indications

Zivastine is indicated for the symptomatic treatment of:

  • Seasonal Allergic Rhinitis (Hay Fever): Alleviates acute nasal congestion, repetitive sneezing, rhinorrhea (runny nose), and red, itchy, watery eyes.

  • Perennial Allergic Rhinitis: Long-term management of indoor allergen triggers such as dust mites, mold spores, and pet dander.

  • Allergic Rhinoconjunctivitis: Comprehensive relief addressing both upper respiratory and ocular symptoms.

  • Chronic Spontaneous Urticaria & Acute Hives: Rapid suppression of wheals, intense skin itching (pruritus), and localized erythema (redness).

3. Why Choose Zivastine? Core Advantages

  • True 24-Hour Continuous Efficacy: A single once-daily dose provides uninterrupted peripheral -blockade throughout the day and night.

  • Minimal Sedation Profile: Engineered with minimal blood-brain barrier penetration, Zivastine does not induce daytime drowsiness or impair cognitive performance.

  • Rapid Onset of Action: Fast-acting active metabolite (Carebastine) rapidly curbs histamine release to relieve symptoms within hours.

  • Orodispersible Technology (ODT): Tablets melt on the tongue for fast intake and higher patient compliance.

  • Flexible Strength Selection:

    • 10 mg: Ideal for mild-to-moderate symptoms and baseline allergic rhinitis.

    • 20 mg: Delivers enhanced symptom control for severe persistent rhinitis and refractory chronic urticaria.

4. Summary of Product Specifications

FeatureSpecification
Generic NameEbastine
Brand NameZivastine
Dosage Strengths10 mg & 20 mg
Dosage FormOrodispersible Tablets (ODT)
Pack Size30 Orodispersible Tablets (3 blisters 10 tablets)
Drug ClassSecond-Generation Antihistamine
ManufacturerZein Pharma Pharmaceutical Industries

5. Dosage & Administration Guidelines

  • Allergic Rhinitis: 10 mg once daily. In cases of severe or persistent symptoms, dosage may be titrated up to 20 mg once daily as advised by a healthcare provider.

  • Chronic Urticaria: 10 mg or 20 mg once daily depending on the severity of urticarial outbreaks.

  • Administration: Place tablet on the tongue until fully dispersed, then swallow. May be taken with or without food.

Disclaimer: This content is for educational and informational purposes only and does not substitute professional medical advice. Always consult a licensed physician or pharmacist for medical diagnosis and treatment plans.

Previous Post
Next Post

1 Comment

  • Autem aliquid quos. Culpa dolores qui reiciendis Ipsam velit quibusdam temporibus repudiandae. Minus suscipit eum ut. Et eius quasi voluptatum magnam aut. Qui dolor quaerat ullam sint. Asperiores nulla quae maiores quaerat. Enim omnis ex incidunt distinctio. Illo earum ea sed. Fuga qui omnis officiis doloribus. Nihil ut et. Porro omnis incidunt voluptas fuga velit. voluptas sequi omnis perspiciatis Dolores corrupti itaque ratione cum alias esse.

Leave a Reply

Your email address will not be published. Required fields are marked *

Committed to advancing global healthcare through the development, manufacturing, and distribution of high-quality pharmaceutical formulations.

Contact Info
Phone: +963986000022
E-Mail: info@zein-pharma.com

© 2026 Zein Pharma. All rights reserved.